About: Critical Complications of COVID-19: A systematic Review and Meta-Analysis study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Critical Complications of COVID-19: A systematic Review and Meta-Analysis study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Critical Complications of COVID-19: A systematic Review and Meta-Analysis study
Creator	Fathi, Mobina Hajiesmaeili, Mohammadreza Mohamadkhani, Ashraf Pezeshgi, Aiyoub Rezaei-Tavirani, Mostafa Sayehmiri, Fatemeh Vakili, Kimia
Source	MedRxiv
abstract	Background: Coronavirus disease 2019 (COVID-19) is a novel coronavirus infection that has spread worldwide in a short period and caused a pandemic. The goal of this meta-analysis is to evaluate the prevalence of most common symptoms and complications of COVID-19. Methods: All related studies assessing the clinical complications of COVID-19 have been identified through web search databases (PubMed and Scopus). Relevant data were extracted from these studies and analyzed by stata (ver 14) random-effects model. The heterogeneity of studies were assessed by I2 index. The publication bias was examined by Funnel plots and Eggers test. Results: 30 studies were in our meta-analysis including 6 389 infected patients. The prevalence of most common symptoms were: fever 84.30% (95% CI: 77.13-90.37; I2=97.74%), cough 63.01% (95% CI: 57.63-68.23; I2=93.73%), dyspnea 37.16% (95% CI: 27.31-47.57%; I2=98.32%), fatigue 34.22% (95% CI: 26.29-42.62; I2=97.29%) and diarrhea 11.47 %(95% CI: 6.96-16.87; I2=95.58%), respectively. The most prevalent complications were acute respiratory distress syndrome (ARDS) 33.15% (95% CI: 23.35-43.73; I2=98.56%), acute cardiac injury 13.77% (95% CI: 9.66-18.45; I2=91.36%), arrhythmia 16.64% (95% CI: 9.34-25.5; I2=92.29%), heart failure 11.50% (95% CI: 3.45-22.83; I2=89.48%), and acute kidney injury (AKI) 8.40 %(95% CI: 5.15-12.31; I2=95.22%, respectively. According to our analysis, mortality rate of COVID-19 patients were 12.29% (95% CI: 6.20-19.99; I2=98.29%). Conclusion: We assessed the prevalence of the main clinical complications of COVID-19 and found that after respiratory complications, cardiac and renal complications are the most common clinical complications of COVID-19.
has issue date	2020-06-16(xsd:dateTime)
bibo:doi	10.1101/2020.06.14.20130955
has license	medrxiv
sha1sum (hex)	759686c6fb76c529f79ad1cbbef1d2677b9d31a2
schema:url	https://doi.org/10.1101/2020.06.14.20130955
resource representing a document's title	Critical Complications of COVID-19: A systematic Review and Meta-Analysis study
resource representing a document's body	covid:759686c6fb76c529f79ad1cbbef1d2677b9d31a2#body_text
is schema:about of	named entity 'arrhythmia' named entity 'evaluate' named entity 'studies' named entity 'meta-analysis' named entity 'COVID-19' named entity 'ver' named entity 'test' named entity 'The' named entity 'databases' named entity '95% CI' named entity 'worldwide' named entity 'systematic' named entity 'MORTALITY RATE' named entity 'RELATED' named entity 'COUGH' named entity '50%' named entity 'COMMON' named entity 'complications' named entity 'common' named entity '95% CI' named entity 'The' named entity 'infection' named entity 'publication bias' named entity 'Funnel' named entity '95% CI' named entity 'angiotensin-converting enzyme 2' named entity 'SARS-CoV' named entity 'identified' named entity 'According' named entity 'AKI' named entity 'stata' named entity 'COVID' named entity 'arrhythmia' named entity 'cough' named entity 'ARDS' named entity 'AKI' named entity 'PubMed' named entity 'publication bias' named entity '5.15' named entity '95% CI' named entity 'dyspnea' named entity 'clinical complications' named entity 'COVID-19' named entity 'China' named entity 'medRxiv' named entity 'effect size' named entity 'fatigue' named entity 'pneumonia' named entity 'STATA' named entity 'mortality rate' named entity '95% CI' named entity 'heart failure' named entity 'Acute myocardial injury' named entity 'infection' named entity 'preprint' named entity '95% CI' named entity 'serum creatinine' named entity 'COVID' named entity 'meta-analysis' named entity '95% confidence interval' named entity '95% CI' named entity 'preprint' named entity 'China' named entity 'intestine' named entity 'diarrhea' named entity 'innate immune responses' named entity 'cardiovascular' named entity 'arrhythmia' named entity 'downregulated' named entity '95% CI' named entity 'ARDS' named entity 'terminally ill' named entity 'preprint' named entity 'clinical outcomes' named entity 'cough' named entity 'NT-proBNP' named entity '11 March 2020' named entity 'fatigue' named entity 'acute respiratory distress syndrome'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software